DOCSLIB.ORG

Narcotic Drugs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Narcotic Drugs EIINCB/1991/2/Supp.2 INTERNATIONAL NARCOTICS CONTROL BOARD - VIENNA SUPPLEMENT No. 2 TO NARCOTIC DRUGS ESTIMATED WORLD REQUIREMENTS FOR 1992 STATISTICS FOR 1990 ESTIMATES UPDATED AS OF 29 FEBRUARY 1992 ORGANE INTERNATIONAL DE CONTROLE DES STUPEFIANTS - VIENNE SUPPLEMENT NO 2 A STUPEFIANTS EVALUATIONS DES BESOINS DU MONDE POUR 1992 STATISTIQUES POUR 1990 EVALUATIONS A JOUR AU 29 FEVRIER 1992 JUNTA INTERNACIONAL DE FISCALlZACION DE ESTUPEFACIENTES - VIENA SUPLEMENTO N.o 2 A ESTUPEFACIENTES PREVISIONES DE LAS NECESIDADES MUNDIALES PARA 1992 ESTADrSTICAS PARA 1990 PREVIS/ONES ACTUALlZADAS AL 29 DE FEBRERO DE 1992 ~16.~~ ~ ~~# UNITED NATIONS - NATIONS UNIES - NACIONES UNIDAS 1992 The updating of Table I is carried out by means of 12 monthly supplements. In order to facilitate the task of the exporting countries, the 12 supplements now report all the totals of the estimates and not only the amended data. In this way, each supplement cancels and replaces the published table in its entirety. In order to accelerate the transmission of the supplements to the competent national authorities, the 12 supplements will appear in English. Reading of these 12 supplements in French and Spanish may be facilitated by consulting the indexes of countries and territories and of narcotic drugs appearing in the annual publication. La mise a jour du tableau I s'effectue au moyen de douze supplements mensuels. Afin de faciliter la tache des pays exportateurs, les douze supplements contiennent tous les totaux des evaluations et non pas seulement les chiffres qui ont ete modifies. De cette maniere, chaque supplement annule et remplace entierement le tableau publie. En vue d'accelerer la communica­ tion des supplements aux autorites competentes, les douze supplements seront publies en anglais. La lecture en franc;:ais et en espagnol de ces douze supplements pourra etre facilitee par la consultation des index des pays et territoires et des stupefiants de la publication annuelle. La actualizaci6n del cuadro I se efectua mediante doce suplementos mensuales. Para facilitar la tarea de los paises exportadores, en esos doce suplementos figuran todos los totales de las previsiones y no s610 las cifras que se han modificado. De este modo. cada suplemento anula y sustituye por completo el cuadro publicado. Con el fin de acelerar la comunicaci6n de los suplementos alas autoridades nacionales competentes, los doce suplementos aparecen en ingh~s. La lectura de estos doce suplementos en espai'lol y en frances se vera facilitada si se consultan los indices de paises y territorios que figuran en la publicaci6n anua!. E/INCB/1991/2/Supp.2 29.2.1992 UNITED NATIONS PUBLICATION ISSN 1013-8250 ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN 1992 TOTAL OF ESTIMATES TOTAL OF ESTIMATES IN GRAMS IN GRAMS AFGHANISTAN ANGOLA CODEINE 189 540 ALFENTANIL 1 ETHYLMORPHINE 1 640 CODEINE 7 620 FENTANYL 10 DEXTROMORAMIDE 1 METHADONE 50 FENTANYL 15 MORPHINE 500 MORPHINE 30 OPIUM 8 000 PETHIDINE 365 PETHIDINE 10 000 ANGUILLA ALBANIA COCAINE 2 COCAINE 534 CODEINE 3 CODEINE 60 925 DIHYDROCODEINE 11 ETHYLMORPHINE 557 FENTANYL 1 FENTANYL 6 MORPHINE 3 MORPHINE 100 PETHIDINE 54 OPIUM 62 000 PETHIDINE 5 437 ANTIGUA AND BARBUDA ALGERIA COCAINE 24 CODEINE 600 ALFENTANIL 2 FENTANYL 2 CODEINE 290 000 MORPHINE 12 DEXTROMORAMIDE 1 000 PETHIDINE 600 ETORPHINE 2 FENTANYL 50 ARGENTINA MORPHINE 350 PETHIDINE 14 000 ALFENTANIL 100 PHENOPERIDINE 350 CANNABIS 10 PHOLCODINE 170 000 CANNABIS RESIN 10 COCA LEAF 20 COCAINE 2 000 CODEINE 400 000 ANDORRA CONC. OF POppy STRAW 500 000 DEXTROPROPOXYPHENE 2000 000 COCAINE 10 DIHYDROCODEINE 80 000 CODEINE 20 DIPHENOXYLATE 5 000 DEXTROMORAMIDE 5 ECGONINE 2 ETHYLMORPHINE 5 ETHYLMORPHINE 60 000 FENTANYL 5 FENTANYL 140 METHADONE 15 HEROIN 2 MORPHINE 20 HYDROCODONE 60 000 OPIUM 5 METHADONE 1 PETHIDINE 200 MORPHINE 430 000 PHENOPERIDINE 10 OPIUM 10 000 TILIDINE 2 OXYCODONE 10 000 PAGE 2 TOTAL OF ESTIMATES TOTAL OF ESTIMATES IN GRAMS IN GRAMS ARGENTINA (continued) AUSTRALIA (continued) ------------------------- ------------------------- OXYMORPHONE 2 000 PETHIDINE 660 000 PETHIDINE 100 000 PETHIDINE INT.-A 700 000 PHOLCODINE 60 010 PHENOPERIDINE 140 SUFENTANIL 100 PHOLCODINE 220 000 THEBAINE 150 000 SUFENTANIL 10 THEBAINE 1000 000 ARUBA TILlDINE 50 000 * ------------------------- BEZITRAMIDE 2 AUSTRIA COCAINE 54 ------------------------- CODEINE 69 ALFENTANIL 170 DEXTROMORAMIDE 2 COCAINE 1 780 DEXTROPROPOXYPHENE 4 CODEINE 172 300 HYDROCODONE 27 DEXTROPROPOXYPHENE 190 000 METHADONE 10 DIHYDROCODEINE 167 700 MORPHINE 62 ETHYLMORPHINE 1 300 OPIUM 900 ETORPHINE 1 OXYCODONE 30 FENTANYL 170 PETHIDINE 1 206 HYDROMORPHONE 100 LEVORPHANOL 10 ASCENSION ISLAND METHADONE 29 700 ------------------------- MORPHINE 54 300 FENTANYL 1 NICOCODINE 16 500 MORPHINE 3 NICOMORPHINE 4 600 PETHIDINE 20 OPIUM 11 000 PETHIDINE 36 000 AUSTRALIA PIRITRAMIDE 6 000 ------------------------- SUFENTANIL 80 ALFENTANIL 10 THEBAINE 1 000 ANILERIDINE 150 000 * CANNABIS 50 BAHAMAS COCAINE 14 000 ------------------------- CODEINE 9250 000 CANNABIS 35 CONC. OF POppy STRAW 40210 000 COCAINE 60 DEXTROMORAMIDE 6 000 CODEINE 1 800 DEXTROPROPOXYPHENE 1000 000 DEXTROPROPOXYPHENE 4 000 DIFENOXIN 10 ECGONINE 1 DIHYDROCODEINE 300 000 ECGONINE BENZOYLESTER 1 DIPHENOXYLATE 90 000 ECGONINE METHYLESTER 1 ECGONINE 5 FENTANYL 1 ETHYLMORPHINE 3 000 HYDROCODONE 300 ETORPHINE 5 MORPHINE 300 FENTANYL 600 * OPIUM 20 HEROIN 10 OXYCODONE 500 HYDROCODONE 1 500 PETHIDINE 9 000 HYDROMORPHONE 10 METHADONE 200 000 BAHRAIN METHADONE-INTERMEDIATE 20 000 ------------------------- MORPHINE 20355 000 COCAINE 89 NORMETHADONE 10 000 * CODEINE 500 OPIUM 31 500 MORPHINE 94 OXYCODONE 270 000 PETHIDINE 4 800 PHENOPERIDINE 1 PAGE 3 TOTAL OF ESTIMATES TOTAL OF ESTIMATES IN GRAMS IN GRAMS BANGLADESH BELGIUM (continued) ------------------------- ------------------------- CODEINE 10 000 PETHIDINE INT.-B 10 METHADONE 261 PHENAZOCINE 10 MORPHINE 25 000 PHENOPERIDINE 10 PETHIDINE 300 000 PHOLCODINE 240 000 PHOLCODINE 150 000 PIRITRAMIDE 250 000 * RACEMETHORPHAN 10 BARBADOS SUFENTANIL 35 ------------------------- THEBACON 35 000 COCAINE 89 THEBAINE 150 010 CODEINE 21 000 TILlDINE 1350 000 FENTANYL 1 HYDROCODONE 122 METHADONE 17 BELIZE MORPHINE 573 ------------------------- OPIUM 3 000 COCAINE 200 OXYCODONE 55 CODEINE 1 500 PETHIDINE 2 503 MORPHINE 50 PETHIDINE 1 500 BELGIUM ------------------------- ACETYLDIHYDROCODEINE 20 000 BENIN ALFENTANIL 800 ------------------------- BEZITRAMIDE 2 000 DEXTROMORAMIDE 12 CANNABIS 50 FENTANYL 2 COCA LEAF 10 000 MORPHINE 15 COCAINE 20 000 OPIUM 5 000 CODEINE 2450 000 PETHIDINE 9 545 CONC. OF POppy STRAW 2000 000 SUFENTANIL 2 DEXTROMORAMIDE 110 000 * DEXTROPROPOXYPHENE 180 000 DIETHYLTHIAMBUTENE 10 DIFENOXIN 10 BERMUDA DIHYDROCODEINE 131 500 ------------------------- DIPHENOXYLATE 820 000 * COCAINE 200 DIPIPANONE 10 CODEINE 2 000 ETHYLMORPHINE 270 000 DEXTROMORAMIDE 15 ETORPHINE 10 DIHYDROCODEINE 1 000 ETOXERIDINE 10 ETORPHINE 5 FENTANYL 250 FENTANYL 1 HEROIN 1 000 METHADONE 400 HYDROCODONE 50 000 MORPHINE 1 500 HYDROMORPHONE 10 OPIUM 100 ISOMETHADONE 10 OXYCODONE 200 LEVOMORAMIDE 10 OXYMORPHONE 1 LEVORPHANOL 10 PETHIDINE 3 000 METHADONE 7 000 MORPHINE 3545 000 BHUTAN NICOMORPHINE 10 ------------------------- NORMETHADONE 15 000 CODEINE 1 950 OPIUM 100 000 DEXTROPROPOXYPHENE 975 OXYCODONE 1 500 MORPHINE 45 PETHIDINE 40 000 PETHIDINE 300 PAGE 4 TOTAL OF ESTIMATES TOTAL OF ESTIMATES IN GRAMS IN GRAMS BOLIVIA BULGARIA ------------------------- ------------------------- ALFENTANIL 20 COCAINE 19 000 CODEINE 9 620 CODEINE 7150 000 DEXTROPROPOXYPHENE 145 000 DEXTROMORAMIDE 50 DIHYDROCODEINE 3 350 DIPHENOXYLATE 30 000 ETHYLMORPHINE 4 100 ETHYLMORPHINE 275 000 FENTANYL 20 FENTANYL 170 HYDROCODONE 4 050 METHADONE 40 METHADONE 26 MORPHINE 352 000 PETHIDINE 6 000 OPIUM noo 000 PETHIDINE no 000 BOTSWANA PIRITRAMIDE 4 500 ------------------------- TILlDINE 65 000 CODEINE 160 DIHYDROCODEINE 1 000 BURKINA FASO DIPIPANONE 3 ------------------------- FENTANYL 1 COCAINE 1 MORPHINE 90 CODEINE 1 PETHIDINE 4 500 DEXTROMORAMIDE 20 TILIDINE 90 FENTANYL 2 HEROIN 1 BRAZIL MORPHINE 30 ------------------------- PETHIDINE 437 ALFENTANIL 400 PHENOPERIDINE 3 CODEINE 2900 000 THEBAINE 1 DEXTROPROPOXYPHENE 6100 000 DIPHENOXYLATE 200 000 BURUNDI FENTANYL 1 500 ------------------------- HYDROCODONE 250 CODEINE 12 000 MORPHINE 2580 000 DEXTROMORAMIDE 1 OPIUM 1020 000 FENTANYL 2 PETHIDINE 600 000 MORPHINE 18 SUFENTANIL 3 PETHIDINE 400 BRITISH VIRGIN ISLANDS CAMBODIA ------------------------- ------------------------- CODEINE 600 COCAINE 2 000 DIHYDROCODEINE 150 CODEINE 50 000 DIPHENOXYLATE 25 ETHYLMORPHINE 1 000 MORPHINE 4 MORPHINE 2 000 PETHIDINE 345 OPIUM 5 000 PETHIDINE 1 000 PHOLCODINE 2 000 BRUNEI DARUSSALAM ------------------------- CAMEROON ALFENTANIL 1 ------------------------- COCAINE 50 DEXTROMORAMIDE 106 CODEINE 1 000 FENTANYL 71 ETORPHINE 1 MORPHINE 1 083 FENTANYL 1 OPIUM 1 574 METHADONE 40 PETHIDINE 18 415 MORPHINE 150 PHENOPERIDINE 12 PETHIDINE 1 500 PHOLCODINE 6 000 PAGE 5 TOTAL OF ESTIMATES TOTAL OF ESTIMATES IN GRAMS IN GRAMS CANADA CENTRAL AFRICAN REPUBLIC (continued) ------------------------- ------------------------- ALFENTANIL 720 DIPHENOXYLATE 125 ALPHAPRODINE 500 OPIUM 135 ANILERIDINE 100 000 PETHIDINE 110 COCAINE 33 000 PHOLCODINE 700 CODEINE 14275 000 DEXTROPROPOXYPHENE 1300 000 CHAD DIFENOXIN 1 ------------------------- DIHYDROCODEINE 1 CODEINE 1 040 DIPHENOXYLATE 19 500 DEXTROMORAMIDE 20 ECGONINE 1 FENTANYL 20 ETHYLMORPHINE 100 MORPHINE 1 136 ETORPHINE 2 PETHIDINE 720 FENTANYL 675 PHENOPERIDINE 13 HEROIN 2 700 HYDROCODONE 81 000
Load more

Recommended publications
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (As of 10 January 2019 )
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (as of 10 January 2019 ) Afghanistan Cannabis 50 Codeine 50 000 Cannabis resin 1 Dextropropoxyphene 10 000 Coca leaf 1 Diphenoxylate 5 000 Cocaine 15 Fentanyl 1 Codeine 650 000 Methadone 20 000 Codeine -N-oxide 1 Morphine 8 000 Dextromoramide 1 Pethidine 90 000 Dextropropoxyphene 200 000 Pholcodine 40 000 Difenoxin 1 Albania Dihydrocodeine 1 Cocaine 1 Diphenoxylate 1 Codeine 1 189 000 Dipipanone 1 Fentanyl 300 Ecgonine 2 Heroin 1 Ethylmorphine 1 Methadone 7 000 Etorphine 1 Morphine 7 800 Fentanyl 17 000 Oxycodone 2 000 Heroin 1 Pethidine 2 700 Hydrocodone 10 000 Pholcodine 1 500 Hydromorphone 4 000 Remifentanil 9 Ketobemidone 1 Sufentanil 2 Levorphanol 1 Algeria Methadone 100 000 Alfentanil 350 Morphine 1 550 000 Codeine 2 500 000 Morphine -N-oxide 1 Etorphine 1 Nicomorphine 1 Fentanyl 500 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba* Methadone 2 000
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Problems of Drug Dependence 1980 Proceedings of the 42Nd Annual Scientific Meeting the Committee on Problems of Drug Dependence
    National Institute on Drug Abuse MONOGRAPH SERIES Problems of Drug Dependence 1980 Proceedings of the 42nd Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Problems of Drug Dependence, 1980 Proceedings of the 42nd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc. Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 34 February 1981 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Division of Research 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 The NIDA Research Monograph series is prepared by the Division of Research of the National Institute on Drug Abuse. Its primary objective is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, integrative research reviews and significant original research. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisory Board Avram Goldstein, M.D. Addiction Research Foundation Palo Alto, California Jerome Jaffe, M.D. College of Physicians and Surgeons Columbia University, New York Reese T. Jones, M.D. Langley Porter Neuropsychiatric Institute University of California San Francisco, California William McGlothlin, Ph.D. Deportment of Psychology, UCLA Los Angeles, California Jack Mendelson, M.D. Alcohol and Drug Abuse Research Center Harvard Medical School McLean Hospital Belmont, Massachusetts Helen Nowlis, Ph.D. Office of Drug Education, DHHS Washington, D.C Lee Robins, Ph.D.
    [Show full text]
  • 2. Study Report Synopsis of Protocol 7164-L-01
    Clinical Trial Report - Study 7164L01 Pholcodine 2. STUDY REPORT SYNOPSIS OF PROTOCOL 7164-L-01 Name of Sponsor Company Individual Study Table referring to the dossier (for National Authority use only) Zambon Group S.p.A. PART: [……] Name of finished product VOLUME: [……] Name of active ingredient Pholcodine PAGE: [……] Title of the study A MULTICENTER, RANDOMIZED, PARALLEL GROUP, CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE EFFICACY AND SAFETY OF PHOLCODINE AS ANTITUSSIVE AGENT VS DEXTROMETORPHAN IN NON-PRODUCTIVE COUGH Principal Investigators and study sites The study took place in Italy and involved 20 recruiters General Practitioners. 101: M. Acciarresi (v. Ponti, Foligno, PG); 102: P. Bonifazi (v. Ponti, Foligno, PG); 103: R. Equinozzi (v. Roma 84/, Foligno, PG); 104: R. Falcinelli (v. Carducci 3, Montefalco, PG); 105: M. Montironi (v. Flaminia Km 182, Gualdo Tadino, PG), 106 L. Pisell (v. Arco di Druso 5, Spoleto, PG); 201 G. Amoretti (v. Repubblica 9, Imperia, IM); 202: A. Astorino, v. Cipressa 32, San Lorenzo al Mare, IM); 203: R. Buccelli (v. S. Antonio 11, Imperia, IM); 204: F. Dolmetta (v. Vignasse 68, San Lorenzo al Mare , IM); 205; G. Lanteri( v. Carducci 1, Imperia, IM); 206: A. Novaro (v. Nazionale 29, Imperia, IM); 207: M. Pinelli (v. Parini 34, Imperia, IM); 301 GL Balderi (v. Carducci 33, Marina di Pietrasanta, LU); 302: F. Bertuccelli (v. Leopardi 35, Viareggio, LU); 303: C. Bonin (v. Montemagno,2, Montemagno, LU); 304: PL Franceschi (v. Misericordia 89, Stiava, LU); 305: M. Pardini (v. Garibaldi 29, Viareggio, LU); 306: M. Pardini (v. Italica 70, Lido di Camaiore, LU); 307: A.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Quality Issues in Caring for Older People
    Doctoral Thesis - Tesis Doctoral Quality issues in caring for older people: • Appropriateness of transition from long-term care facilities to acute hospital care • Potentially inappropriate medication: development of a European list Anna Renom Guiteras Prof. Gabriele Meyer Prof. Ramón Miralles Basseda Martin Luther University Halle-Wittenberg Universitat Autònoma de Barcelona Halle (Saale) & Barcelona, Catalonia University of Witten/Herdecke Spain Witten Germany Programa de doctorat en Medicina Departament de Medicina, Facultat de Medicina Universitat Autònoma de Barcelona Barcelona, 2015 13 Contents 15 1. Introduction • Research context • Background of the research topics • Pesetaio of the ailes 23 2. Summary and discussion of the results 31 3. Conclusions 37 4. References 47 5. Articles • Article 1: Renom-Guiteras A, Uhrenfeldt L, Meyer G, Mann E. Assessment tools for determining appropriateness of admission to acute care of persons transferred from long-term care facilities: a systematic review. BMC Geriatr. 2014;14:80 • Article 2: Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861-75 77 6. Annexes • Annex 1.1 (article 1) - Additional file 1: Studies dealing with assessment tools for determining appropriateness of hospital admissions among residents of LTC facilities. • Annex 1.2 (article 1) - Additional file 2: Characteristics of the assessment tools for determining appropriateness of hospital admissions among residents of LTC facilities. • Annex 2.1 (article 2) - Appendix 1: Complete EU(7)-PIM list • Annex 2.2 (article 2) - Appendix 2: Questionable Potentially Inappropriate Medications (Questionable PIM): results of the Delphi survey.
    [Show full text]
  • Misuse and Abuse of Opioid Analgesics – the Role of the Internet
    Misuse and Abuse of Opioid Analgesics – the Role of the Internet H. Siemann, J. Schnell, N. Scherbaum LVR Hospital Essen, Clinic for Dependent Behavior and Addiction Medicine University of Duisburg-Essen, Germany Misuse and Abuse of Opioid Analgesics – the Role of the Internet 09/18/2009 Opioid Analgesics • Prescription Drugs – Tramadol, Tilidine, Codeine, Loperamide – Easy to prescribe • Schedule III Drugs according to the German Narcotics Act (BtmG) – Morphine, Methadone, Fentanyl, Buprenorphine, Oxycodone – Special conditions to be fulfilled for a valid presciption Holger Siemann ([email protected]) 2 Misuse and Abuse of Opioid Analgesics – the Role of the Internet 09/18/2009 Prescription Rate Holger Siemann ([email protected]) 3 Misuse and Abuse of Opioid Analgesics – the Role of the Internet 09/18/2009 Non-Scheduled Opioids • Tramadol – Pain management (post-surgery treatment, injury treatment) • Tilidine + Naloxone (Valoron N®) – Higher analgesic potency – Prevention of parenteral drug abuse by combination with the µ-receptor antagonist Naloxone Holger Siemann ([email protected]) 4 Misuse and Abuse of Opioid Analgesics – the Role of the Internet 09/18/2009 Aim of the Study • To assess the role of the internet regarding the abuse of prescription opioids – Role as a trading platform – Role as an information system Holger Siemann ([email protected]) 5 Misuse and Abuse of Opioid Analgesics – the Role of the Internet 09/18/2009 Methods • Analysis of the first 50 websites provided by the leading search engine Google for
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Malta Medicines List April 08
    Defined Daily Doses Pharmacological Dispensing Active Ingredients Trade Name Dosage strength Dosage form ATC Code Comments (WHO) Classification Class Glucobay 50 50mg Alpha Glucosidase Inhibitor - Blood Acarbose Tablet 300mg A10BF01 PoM Glucose Lowering Glucobay 100 100mg Medicine Rantudil® Forte 60mg Capsule hard Anti-inflammatory and Acemetacine 0.12g anti rheumatic, non M01AB11 PoM steroidal Rantudil® Retard 90mg Slow release capsule Carbonic Anhydrase Inhibitor - Acetazolamide Diamox 250mg Tablet 750mg S01EC01 PoM Antiglaucoma Preparation Parasympatho- Powder and solvent for solution for mimetic - Acetylcholine Chloride Miovisin® 10mg/ml Refer to PIL S01EB09 PoM eye irrigation Antiglaucoma Preparation Acetylcysteine 200mg/ml Concentrate for solution for Acetylcysteine 200mg/ml Refer to PIL Antidote PoM Injection injection V03AB23 Zovirax™ Suspension 200mg/5ml Oral suspension Aciclovir Medovir 200 200mg Tablet Virucid 200 Zovirax® 200mg Dispersible film-coated tablets 4g Antiviral J05AB01 PoM Zovirax® 800mg Aciclovir Medovir 800 800mg Tablet Aciclovir Virucid 800 Virucid 400 400mg Tablet Aciclovir Merck 250mg Powder for solution for inj Immunovir® Zovirax® Cream PoM PoM Numark Cold Sore Cream 5% w/w (5g/100g)Cream Refer to PIL Antiviral D06BB03 Vitasorb Cold Sore OTC Cream Medovir PoM Neotigason® 10mg Acitretin Capsule 35mg Retinoid - Antipsoriatic D05BB02 PoM Neotigason® 25mg Acrivastine Benadryl® Allergy Relief 8mg Capsule 24mg Antihistamine R06AX18 OTC Carbomix 81.3%w/w Granules for oral suspension Antidiarrhoeal and Activated Charcoal
    [Show full text]
  • Guidelines for Ensuring Patient Access To, and Safe Management Of, Controlled Medicines Notice
    African Palliative Care Association Guidelines for Ensuring Patient Access to, and Safe Management of, Controlled Medicines Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. APCA and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of this publication. However, in view of the possibility of human error or changes in sciences, neither APCA nor the publisher nor any other party who have been involved in the preparation or publication of this work warrants that the information contained in this publication is complete and correct and they disclaim all responsibility for any errors or omission or for the results obtained from use of the information contained herein. African Palliative Care Association Foreword The 59th Session of the World Health conventions. Several countries make the Assembly of the UN adopted resolution importation, storage, distribution and 58.22, thereby recognising the dispensing of controlled medicines more importance of improving pain relief restrictive than is needed. Additionally, using opioid analgesics and calling on it is a requirement for countries to member states to remove barriers to provide detailed annual estimates and their medical use and availability. reports for narcotic substances to the International Narcotic Control Board to While advances have been made pursuing procure or produce controlled medicines. this agenda in Africa (e.g. legalisation of However, formulating reliable estimates oral morphine prescription rights for nurses is often a barrier to accessing controlled and clinical officers in Uganda, approval medicines, while the procurement of access to morphine for hospices of opioids is subject to complex and in Zambia, and advocacy progress in lengthy exportation and importation Malawi and Kenya), challenges remain.
    [Show full text]